Article Title : [Not specified in the provided content] News Publication Date : [Not specified in the provided content] Web References : doi:10.1001/jamahealthforum.2025.4258 Keywords : Peptides, Agonists, Cohort studies, Racial differences, Ethnicity, Medications, Pharmaceuticals, Health care costs, Health insurance Tags: chronic disease management inequalitieseconomic factors in medication adherenceGLP-1 receptor agonists prescription disparitiesglycemic control and weight managementhealthcare equity in pharmaceutical accessmedication adherence in type 2 diabetesnon-Hispanic Black and Hispanic health disparitiesout-of-pocket costs for diabetes medicationspolicy implications for diabetes careprescription fill rates by demographicrace and ethnicity in diabetes treatmentsystemic barriers in healthcare access
doi: 10.1371/journal.pone.0179538 76 StanleyTLChenCYBranchKLMakimuraHGrinspoonSK
Most major telehealth platforms serve 40-50 states
Reductions in baseline body weight of 5%, 10%, and 15% were also evaluated categorically
With so many weight loss medications available from Novo Nordisk's Ozempic and Wegovy to Eli Lilly's Mounjaro and Zepbound it can be tough to compare prices, coverage, and side effects
